Menopause & midlife

Compounded Hormones: Why Insurance Says No

Save

Insurance rarely covers custom-compounded hormones or pellets because they are not FDA-approved, so plans classify them as unproven and exclude them. FDA-approved bioidentical hormones, including estradiol patches and micronized progesterone, contain the same molecules, carry stronger safety data, and are usually covered at a fraction of the compounded cash price.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Why won't insurance cover compounded hormones?

Coverage decisions hinge on FDA approval, and compounded hormones do not have it. A compounding pharmacy custom-mixes these preparations for one person, so they never go through the large trials FDA-approved drugs must pass, and insurers classify unapproved products as experimental.

According to the Menopause Society, custom-compounded hormone therapy is not recommended over FDA-approved options because purity, dose consistency, and safety are not verified 1. Standard hormone therapy uses the same estradiol and progesterone with documented dosing, and for healthy women under 60 or within 10 years of menopause its benefits generally outweigh the risks 1. Any breast-cancer signal from combined therapy is small and linked mainly to use beyond 3 to 5 years 1. A covered FDA-approved form exists for nearly every menopausal symptom.

Are compounded hormones any different from FDA-approved ones?

Chemically the hormones are often identical; the difference is oversight. FDA-approved bioidentical products contain the same 17-beta estradiol or micronized progesterone found in many compounds, but each batch is tested for potency and contamination.

According to MedlinePlus, hormone therapy is available as regulated pills, patches, gels, and vaginal preparations, giving most people a covered route to the same benefit 2. Marketing that frames compounded 'bioidentical' hormones as more natural or safer is not supported by the evidence. For vaginal dryness or hot flashes, a covered FDA-approved form treats the symptom just as well. Checking whether the same molecule exists in a covered product is usually the fastest fix.

What do compounded hormones actually cost out of pocket?

Out-of-pocket pricing is the main downside, since the full cost lands on you. Compounded creams and capsules are typically billed monthly at cash rates, and pellet insertions are often sold as a package every 3 to 4 months, so the yearly total can climb well past what a covered generic would cost.

According to the Menopause Society, there is no evidence that pellets, which deliver supraphysiologic hormone levels, are safer, and those elevated levels may raise side-effect risk 1. A good-faith estimate can reveal the true annual price before you commit. Requesting that estimate in writing protects you from an unexpected annual bill. Comparing that figure with a covered generic often shows a large gap.

When might paying for compounded hormones make sense?

A narrow set of situations can justify compounding, and a clinician can identify them. Someone with a documented allergy to a dye or filler in every commercial product, or who needs a dose or combination that is not manufactured, may have a legitimate reason, and some plans grant a formulary exception with that documentation.

Needs also change across life stages: a woman in perimenopause may need only cyclical support, while someone with early menopause before age 40 is generally advised to use estrogen until about age 51 — nearly always achievable with covered products 3. For most people an FDA-approved option works, so compounding stays a rare exception rather than a first choice.

When compounded hormone coverage needs a clinician

A clinician can translate 'my hormones aren't covered' into a covered plan that works. A gynecologist, primary care clinician, or menopause specialist can confirm whether an FDA-approved product fits your needs, document any true medical reason for compounding, and file an exception request when one is warranted.

Bringing your denial letter and formulary to the visit speeds this up. Gale can help you organize those documents and questions beforehand. Where a covered generic will do, switching usually cuts the cost sharply without changing the hormones you receive. Even when a plan first says no, an FDA-approved substitute usually resolves both the cost and the coverage question.

Common questions

Because they are not FDA-approved. Compounded preparations are custom-mixed for one person and never go through the trials approved drugs must pass, so insurers classify them as experimental and exclude them. FDA-approved estrogen and progesterone are the covered alternatives.

The evidence does not support that. FDA-approved bioidentical products contain the same molecules and are tested for potency and purity, while compounded versions are not. Major menopause groups do not consider compounded preparations preferable.

Rarely. Pellets are compounded, not FDA-approved, and often sold as a cash package every few months. There is no evidence they are safer, and the high hormone levels they produce may increase side effects.

Ask about FDA-approved bioidentical options like estradiol patches and micronized progesterone, which are usually covered on low tiers. If you have a true medical reason for compounding, your clinician can document it and request a formulary exception.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When hormone choices need a clinician's review

  • —Symptoms that do not improve on any hormone product are a reason to seek clinician review of the diagnosis and plan.
  • —Unexplained vaginal bleeding after menopause is a reason to seek clinician review before starting or continuing any hormone.
  • —Side effects you suspect from a compounded product are a reason to seek prompt clinician review, since dosing is not standardized.
  • —A denial for compounded hormones is a reason to ask your clinician about covered FDA-approved equivalents or an exception request.

This article is general health education about insurance coverage, not medical or financial advice. Whether any hormone product fits you is a decision for a gynecologist, primary care clinician, or menopause specialist who knows your history.

References

  1. 1.The North American Menopause Society (Menopause Society) (2022). The 2022 Hormone Therapy Position Statement of The North American Menopause Society. Menopause. doi:10.1097/GME.0000000000002028 ✓Custom-compounded hormone therapy is not recommended over FDA-approved options; benefits of FDA-approved therapy generally outweigh risks for healthy women under 60 or within 10 years of menopause; any breast-cancer signal from combined therapy is small and linked to use beyond 3 to 5 years; pellets are not shown to be safer.
  2. 2.MedlinePlus (National Library of Medicine) (2026). Hormone Replacement Therapy. MedlinePlus, U.S. National Library of Medicine (NIH). link ✓Hormone replacement therapy is available in regulated pill, patch, gel, and vaginal forms; supports that a covered FDA-approved form delivers the same estrogen or progesterone as a compounded preparation.
  3. 3.Webber L, et al. (ESHRE) (2016). ESHRE Guideline: management of women with premature ovarian insufficiency. Human Reproduction. doi:10.1093/humrep/dew027 ✓Women with early menopause before age 40 are advised to use estrogen therapy until about the average age of natural menopause (~51); supports that covered products meet this need in almost all cases.

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library